ArticleOncology letters2018

Synergistic antitumor activity of aspirin and erlotinib: Inhibition of p38 enhanced aspirin plus erlotinib-induced suppression of metastasis and promoted cancer cell apoptosis.

Xiu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.